Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,777,716
-
Share change
-
-67,735
-
Total reported value
-
$342,726,354
-
Put/Call ratio
-
114%
-
Price per share
-
$123.52
-
Number of holders
-
76
-
Value change
-
-$7,428,997
-
Number of buys
-
49
-
Number of sells
-
25
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2015
As of 31 Mar 2015,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,777,716 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, MATHER GROUP, INC., Wharton Business Group, LLC, LPL Financial LLC, NIEMANN CAPITAL MANAGEMENT INC, Hoxton Financial, Inc., and CREDIT SUISSE AG/.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.